These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 2012406

  • 21. Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy.
    Persiani R, D'Ugo D, Rausei S, Sermoneta D, Barone C, Pozzo C, Ricci R, La Torre G, Picciocchi A.
    J Surg Oncol; 2005 Mar 15; 89(4):227-36; discussion 237-8. PubMed ID: 15726615
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [A case of AFP (alpha-fetoprotein) producing gastric cancer successfully treated with EAP (etoposide, adriamycin, cisplatin) therapy].
    Gonda T, Ishida H, Higuchi T, Hirukawa H, Nakajima H, Hojo I, Mishima Y.
    Gan To Kagaku Ryoho; 1994 Aug 15; 21(10):1659-63. PubMed ID: 7520221
    [Abstract] [Full Text] [Related]

  • 26. [Effect of preoperative THP-FLPM (pirarubicin, 5-fluorouracil, leucovorin, cisplatin, mitomycin C) therapy on far advanced gastric cancer with peritoneal dissemination].
    Yano M, Tsujinaka T, Shiozaki H, Inoue M, Doki Y, Taniguchi M, Murata A, Monden M.
    Gan To Kagaku Ryoho; 1998 Jan 15; 25(1):139-42. PubMed ID: 9464342
    [No Abstract] [Full Text] [Related]

  • 27. Combination chemotherapy with Tegafur. Uracil (UFT), etoposide, adriamycin and cisplatinum (UFT-EAP) for advanced gastric cancer.
    Hayakawa M, Morise K, Chin K, Sugihara M, Morooka Y, Maeda H, Hattori T, Saito H.
    Jpn J Clin Oncol; 1994 Oct 15; 24(5):282-8. PubMed ID: 7967107
    [Abstract] [Full Text] [Related]

  • 28. [Evaluation of TS-1 combined with cisplatin for neoadjuvant chemotherapy in patients with advanced gastric cancer].
    Yabusaki H, Nashimoto A, Tanaka O.
    Gan To Kagaku Ryoho; 2003 Nov 15; 30(12):1933-40. PubMed ID: 14650962
    [Abstract] [Full Text] [Related]

  • 29. [A gastric cancer patient with marked para-aortic lymph node metastasis surviving more than 10 years after aggressive operation and repeated EAP chemotherapy].
    Uchinami M, Horiuchi T, Aotake T, Matsumura M, Yokomachi J, Tanaka K, Tabo T, Tanigawa N.
    Gan To Kagaku Ryoho; 2002 Mar 15; 29(3):449-53. PubMed ID: 11915738
    [Abstract] [Full Text] [Related]

  • 30. [Evaluation of neoadjuvant chemotherapy with paclitaxel, 5-fluorouracil and cisplatin for advanced gastric cancer with pyloric stenosis].
    Yamaguchi K, Nakagawa S, Yabusaki H, Nashimoto A.
    Gan To Kagaku Ryoho; 2007 Dec 15; 34(13):2241-4. PubMed ID: 18079622
    [Abstract] [Full Text] [Related]

  • 31. [Effect of PMUE therapy (CDDP, MMC, UFT, etoposide) in terminal gastric cancer].
    Sawa T, Kinoshita K, Takekawa S, Ohyama S, Hasegawa K, Fujimura T, Ueda N, Watanabe T, Kato M, Miyata T.
    Gan To Kagaku Ryoho; 1990 Dec 15; 17(12):2381-6. PubMed ID: 2260875
    [Abstract] [Full Text] [Related]

  • 32. Neoadjuvant chemotherapy, radical resection with intraoperative radiation therapy (IORT): improved treatment for gastric adenocarcinoma.
    Weese JL, Harbison SP, Stiller GD, Henry DH, Fisher SA.
    Surgery; 2000 Oct 15; 128(4):564-71. PubMed ID: 11015089
    [Abstract] [Full Text] [Related]

  • 33. 7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study.
    Persiani R, Rausei S, Pozzo C, Biondi A, Barone C, Cananzi FC, Schinzari G, D'Ugo D.
    Ann Surg Oncol; 2008 Aug 15; 15(8):2146-52. PubMed ID: 18543037
    [Abstract] [Full Text] [Related]

  • 34. Combination of etoposide, adriamycin and cisplatin (EAP) in gastric cancer: association with severe toxicity.
    Villar-Grimalt A, Candel MT, Garcia J, Bernacer B, Jimeno J.
    Ann Oncol; 1991 Apr 15; 2(4):310-1. PubMed ID: 1868028
    [No Abstract] [Full Text] [Related]

  • 35. [Peritoneal dissemination of scirrhous type 4 gastric cancers].
    Koufuji K, Aoyagi K, Yano S, Murakami N, Miyagi M, Imaizumi T, Shirouzu K.
    Gan To Kagaku Ryoho; 2005 Oct 15; 32(10):1384-8. PubMed ID: 16227734
    [Abstract] [Full Text] [Related]

  • 36. Response to neoadjuvant chemotherapy and effects of tumor regression in gastric cancer.
    D'Ugo D, Persiani R, Rausei S, Biondi A, Vigorita V, Boccia S, Ricci R.
    Eur J Surg Oncol; 2006 Dec 15; 32(10):1105-9. PubMed ID: 16930932
    [Abstract] [Full Text] [Related]

  • 37. [Neoadjuvant chemotherapy for advanced gastric cancer with para-aortic lymph node metastasis].
    Uehara S, Murabayashi K, Kusta T, Takahashi K, Ogawa T, Onishi H, Saegusa S, Noda N, Okanami Y, Nakamura I.
    Gan To Kagaku Ryoho; 2001 Oct 15; 28(10):1413-8. PubMed ID: 11681249
    [Abstract] [Full Text] [Related]

  • 38. [Recurrence and survival rate of advanced gastric cancer after preoperative EAP-II intra-arterial infusion therapy].
    Masuyama M, Taniguchi H, Takeuchi K, Miyata K, Koyama H, Tanaka H, Higashida T, Koishi Y, Mugitani T, Yamaguchi T.
    Gan To Kagaku Ryoho; 1994 Sep 15; 21(13):2253-5. PubMed ID: 7944452
    [Abstract] [Full Text] [Related]

  • 39. A new schedule for etoposide, epidoxorubicin and cisplatin with granulocyte colony stimulating factor for advanced gastric cancer: a feasibility study.
    Pronzato P, Vigani A, Pensa F, Botto F, Ghio E, Neri E, Tognoni A, Vaira F.
    Anticancer Res; 1997 Sep 15; 17(5B):3873-6. PubMed ID: 9427795
    [Abstract] [Full Text] [Related]

  • 40. Phase II trial of etoposide, doxorubicin (Adriamycin), and cisplatin (EAP regimen) in advanced gastric cancer.
    Sparano JA, Schwartz EL, Salva KM, Pizzillo MF, Wadler S, Wiernik PH.
    Am J Clin Oncol; 1990 Oct 15; 13(5):374-8. PubMed ID: 2220657
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.